Clinical characteristics of patients with sarcoidosis: age, gender, smoking habits, mode of onset, chest radiographic disease stage, smoking habits and treatment with inhaled steroids
| Patient no. | Age (years)/sex | Smoker | Stage (0–III)* | Treatment | Onset |
| 1 | 35/M | No | I | No | Acute |
| 2 | 34/F | No | II | No | Insidious |
| 3 | 63/M | Yes | II | No | Insidious |
| 4 | 29/M | Yes | II | No | Acute |
| 5 | 33/M | Yes | II | No | Insidious |
| 6 | 58/M | No | I | No | Acute |
| 7 | 50/M | No | I | No | Acute |
| 8 | 26/F | Yes | I | No | Insidious |
| 9 | 24/F | No | II | No | Insidious |
| 10 | 39/M | No | II | No | Acute |
| 11 | 39/M | No | I | No | Acute |
| 12 | 23/M | Yes | I | No | Acute |
| 13 | 25/F | Yes | I | No | Acute |
| 14 | 43/M | No | III | No | Insidious |
| 15 | 44/F | No | II | No | Insidious |
| 16 | 32/F | No | I | No | Acute |
| 17 | 41/M | No | III | No | Acute |
| 18 | 54/M | No | II | Inhaled | Insidious |
| 19 | 38/M | Yes | I | No | Acute |
| 20 | 62/F | No | I | No | Insidious |
| 21 | 44/M | No | III | Inhaled | Insidious |
| 22 | 63/M | No | 0 | No | Insidious |
| 23 | 37/F | No | I | No | Insidious |
| 24 | 48/M | No | II | No | Acute |
| 25 | 49/M | Yes | I | No | Insidious |
| 26 | 44/F | No | I | No | Acute |
| 27 | 48/F | No | III | No | Insidious |
| 28 | 52/F | No | I | No | Acute |
| 29 | 43/M | No | III | No | Insidious |
| 30 | 36/F | Yes | II | No | Acute |
| 31 | 34/M | No | I | No | Acute |
| 32 | 39/M | Yes | I | No | Insidious |
| 33 | 58/F | No | III | No | Insidious |
| 34 | 33/M | Yes | I | No | Acute |
| 35 | 29/F | Yes | I | No | Acute |
| 36 | 47/F | No | III | Inhaled | Insidious |
↵* Stages of disease depicted by chest x-ray: stage 0, normal; stage I, bilateral hilar lymphoma (BHL); stage II, BHL and parenchymal infiltrates; stage III, parenchymal infiltrates.